Mice Model Market Size, Share, and Growth Analysis, By Model Type (Inbred Mice, Outbred Mice), By Technology (CRISPR / Gene-Editing, Embryonic Stem Cell Injection), By Application, By End-User, By Region - Industry Forecast 2025-2032

Global Mice Model Market size was valued at USD 1.6 billion in 2023 and is poised to grow from USD 1.71 billion in 2024 to USD 2.84 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2025-2032).

The Global Mice Model Market is significantly influenced by the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions, prompting healthcare systems to emphasize early diagnosis and therapeutic innovations. Pharmaceutical and biotech companies increasingly utilize mice as essential preclinical testing models due to their genetic, biological, and behavioral parallels with humans, thereby enhancing the understanding of disease progression and therapy evaluation. This surge in chronic disease prevalence drives substantial research and development investments, subsequently increasing the demand for sophisticated mice models to facilitate drug discovery. Additionally, the rapid evolution of genetic engineering techniques, particularly CRISPR-Cas9, is transforming the sector by enabling precise creation of transgenic and humanized models, subsequently enhancing the accuracy of preclinical studies and expediting therapeutic advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mice Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mice Model Market Segments Analysis

Global Mice Model Market is segmented by Model Type, Technology, Application, End-User and region. Based on Model Type, the market is segmented into Inbred Mice, Outbred Mice, Genetically Engineered Mice (GEM) and Hybrid / Congenic Mice. Based on Technology, the market is segmented into CRISPR / Gene-Editing, Embryonic Stem Cell Injection, Microinjection / Nuclear Transfer and Traditional Breeding & Rederivation. Based on Application, the market is segmented into Drug Discovery & Development, Disease Modeling (Oncology, Immunology, Neurology, Metabolic), Toxicology & Safety Pharmacology and Personalized / Translational Research. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations (CROs) and Government & Regulatory Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Mice Model Market

The rising prevalence of chronic illnesses, including cancer, diabetes, and cardiovascular diseases, significantly propels the growth of the global mice model market. Mice models play a pivotal role in understanding disease mechanisms and assessing potential therapeutic interventions. Their importance in facilitating drug discovery cannot be overstated, as researchers increasingly rely on these models to innovate and develop effective treatments. This escalating demand for advanced therapies underscores the necessity of mice models in the biomedical research landscape, driving advancements that aim to improve patient outcomes and address the urgent healthcare challenges associated with chronic diseases.

Restraints in the Global Mice Model Market

The global Mice Model market encounters several challenges primarily due to the substantial costs linked to the breeding, upkeep, and housing of laboratory mice. The need for specialized facilities, the employment of skilled personnel, and adherence to strict ethical standards considerably elevate operational expenses. These financial barriers can restrict access for smaller research institutions, hindering their ability to participate effectively in this market. Additionally, these constraints disproportionately impact developing regions, where resources are already limited. As a result, the overall growth of the market is stymied, making it difficult for a wide range of institutions to contribute to advancements in research and development.

Market Trends of the Global Mice Model Market

The Global Mice Model market is experiencing a significant trend towards the increased adoption of humanized and transgenic mice models among pharmaceutical and biotech companies. These advanced models offer enhanced capabilities for accurately simulating human disease conditions, which in turn improves the predictive value of preclinical studies. As companies aim to expedite drug discovery processes and minimize failure rates during clinical trials, the demand for these sophisticated mice models continues to grow. This shift not only fuels innovation within the industry but also establishes a pathway for more effective therapeutic interventions, solidifying the essential role of advanced mice models in biomedical research.